CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Stanford, California, United States and 18 other locations
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
San Francisco, California, United States and 22 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
San Francisco, California, United States and 9 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Mountain View, California, United States and 24 other locations
This feasibility study is a prospective, single center, multi-arm study evaluating possible enhancements to the SteadiSet extended wear infusion set.
Stanford, California, United States
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Walnut Creek, California, United States and 45 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Concord, California, United States and 40 other locations
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...
Phase 3
Palo Alto, California, United States and 59 other locations
This study will examine the safety of three times weekly SC injections of OPT101 at each of three dose levels over two weeks as well as one year of t...
Phase 2
Walnut Creek, California, United States and 4 other locations
can improve patient outcomes for people over the age of 50 with diabetic foot ulcers. The study aims to determine the incidence of complete ...
San Francisco, California, United States of America and 1 other location
Clinical trials
Research sites
Resources
Legal